Sherbrooke Park Advisers’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-33,573
Closed -$328K 1255
2024
Q2
$328K Sell
33,573
-84,679
-72% -$1.03M 0.06% 583
2024
Q1
$1.79M Buy
118,252
+101,624
+611% +$1.84M 0.35% 36
2023
Q4
$358K Sell
16,628
-19,941
-55% -$368K 0.17% 222
2023
Q3
$680K Buy
+36,569
New +$854K 0.22% 178

Other funds holding TDOC

Sherbrooke Park Advisers's TDOC Position: Q3 2024 in Review

Sherbrooke Park Advisers sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 33,573 shares — an estimated $328K sold.

Sherbrooke Park Advisers first reported a position in TDOC in Q3 2023 and held it in 4 quarters. The position peaked at $1.79M in Q1 2024. 365 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • Sherbrooke Park Advisers reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 33,573 Teladoc Health shares in Q3 2024, an estimated $328K.
  • Sherbrooke Park Advisers first reported a position in Teladoc Health in Q3 2023 and held it in 4 quarters.
  • Sherbrooke Park Advisers's Teladoc Health position peaked at $1.79M in Q1 2024.
  • 365 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.